Published in J Immunol on September 12, 2011
Intestinal Microbiota Modulates Gluten-Induced Immunopathology in Humanized Mice. Am J Pathol (2015) 1.51
Novel role of the serine protease inhibitor elafin in gluten-related disorders. Am J Gastroenterol (2014) 1.48
Novel players in coeliac disease pathogenesis: role of the gut microbiota. Nat Rev Gastroenterol Hepatol (2015) 1.08
Remission without insulin therapy on gluten-free diet in a 6-year old boy with type 1 diabetes mellitus. BMJ Case Rep (2012) 1.00
Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiol (2015) 0.98
Dietary gluten alters the balance of pro-inflammatory and anti-inflammatory cytokines in T cells of BALB/c mice. Immunology (2013) 0.89
Lessons from rodent models in celiac disease. Mucosal Immunol (2014) 0.85
Gut microbes and adverse food reactions: Focus on gluten related disorders. Gut Microbes (2014) 0.81
Animal models to study gluten sensitivity. Semin Immunopathol (2012) 0.80
Prevention or early cure of type 1 diabetes by intranasal administration of gliadin in NOD mice. PLoS One (2014) 0.79
Latest in vitro and in vivo models of celiac disease. Expert Opin Drug Discov (2013) 0.79
Intraluminal administration of poly I:C causes an enteropathy that is exacerbated by administration of oral dietary antigen. PLoS One (2014) 0.79
BL-7010 demonstrates specific binding to gliadin and reduces gluten-associated pathology in a chronic mouse model of gliadin sensitivity. PLoS One (2014) 0.75
Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease. Sci Rep (2016) 0.75
Sensitization to and Challenge with Gliadin Induce Pancreatitis and Extrapancreatic Inflammation in HLA-DQ8 Mice: An Animal Model of Type 1 Autoimmune Pancreatitis. Gut Liver (2016) 0.75
A commensal Bifidobacterium longum strain improves gluten-related immunopathology in mice through expression of a serine protease inhibitor. Appl Environ Microbiol (2017) 0.75
Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology (1992) 10.44
Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev (2006) 10.24
Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet (2009) 10.02
Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med (2003) 7.80
Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med (2008) 7.66
Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med (1997) 7.42
Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature (2011) 5.41
Coeliac disease. Lancet (2003) 4.47
Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology (1999) 4.18
Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA (2003) 4.00
Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity (2011) 3.92
IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol (2007) 3.82
Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology (2009) 3.73
Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA (2005) 3.61
Type 1 diabetes. Lancet (2006) 3.61
Gluten sensitivity: from gut to brain. Lancet Neurol (2010) 3.33
Celiac disease: from pathogenesis to novel therapies. Gastroenterology (2009) 2.84
Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol (2002) 2.51
Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends Immunol (2008) 2.50
Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes (2006) 2.29
Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Invest (2007) 2.28
The geoepidemiology of type 1 diabetes. Autoimmun Rev (2009) 1.87
Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut (2003) 1.84
In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes. Eur J Immunol (2010) 1.82
Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand J Gastroenterol (2006) 1.81
Gluten-free diet prevents diabetes in NOD mice. Diabetes Metab Res Rev (1999) 1.77
Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol (1998) 1.72
Gluten-dependent diabetes-related and thyroid-related autoantibodies in patients with celiac disease. J Pediatr (2000) 1.69
Induction of type I diabetes by interferon-alpha in transgenic mice. Science (1993) 1.68
Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci U S A (2005) 1.65
Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia (2006) 1.65
Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab (2004) 1.60
Diagnosis of coeliac disease. Best Pract Res Clin Gastroenterol (2005) 1.60
Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation. Curr Protoc Immunol (2009) 1.54
Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in Celiac disease. J Immunol (2006) 1.51
Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells. Trends Immunol (2004) 1.42
Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice. Am J Physiol Gastrointest Liver Physiol (2007) 1.42
Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci (2009) 1.39
Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion. J Immunol (2003) 1.32
The NOD mouse: a model for insulin-dependent diabetes mellitus. Curr Protoc Immunol (2001) 1.31
HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol (2002) 1.30
Annual screening detects celiac disease in children with type 1 diabetes. Pediatr Diabetes (2008) 1.26
A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J Clin Invest (2004) 1.23
Mucosa-associated (beta 7-integrinhigh) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior. Diabetes (1996) 1.23
Enteropathy precedes type 1 diabetes in the BB rat. Gut (2004) 1.19
In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes. J Exp Med (2000) 1.17
Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes. J Pediatr Gastroenterol Nutr (2005) 1.17
Coeliac disease and diabetes mellitus: a study of 24 patients with HLA typing. Q J Med (1982) 1.17
High frequency of coeliac disease in adult patients with type-I diabetes. Scand J Gastroenterol (1989) 1.17
Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia (2009) 1.16
T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function. J Immunol (2009) 1.16
Mucosal addressin is required for the development of diabetes in nonobese diabetic mice. J Immunol (1998) 1.13
Health care use and costs in the decade after identification of type 1 and type 2 diabetes: a population-based study. Diabetes Care (2006) 1.13
Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies. J Autoimmun (2004) 1.12
Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium. Gastroenterology (2008) 1.12
Partial depletion of CD69low-expressing natural regulatory T cells with the anti-CD25 monoclonal antibody PC61. Scand J Immunol (2007) 1.11
Host responses to intestinal microbial antigens in gluten-sensitive mice. PLoS One (2009) 1.08
Leaking gut in type 1 diabetes. Curr Opin Gastroenterol (2008) 1.08
Islet beta-cell-specific T cells can use different homing mechanisms to infiltrate and destroy pancreatic islets. Am J Pathol (2007) 1.07
Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells. J Immunol (2009) 1.07
Intraepithelial lymphocytes in the villous tip: do they indicate potential coeliac disease? J Clin Pathol (2004) 1.03
Six months of gluten-free diet do not influence autoantibody titers, but improve insulin secretion in subjects at high risk for type 1 diabetes. J Clin Endocrinol Metab (2003) 1.03
Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse. Methods Mol Biol (2007) 1.03
Cow's milk and type 1 diabetes: the real debate is about mucosal immune function. Diabetes (1999) 1.02
Diabetes-specific HLA-DR-restricted proinflammatory T-cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes. Diabetes (2009) 1.02
Clustering and commonalities among autoimmune diseases. J Autoimmun (2009) 1.01
Where are all those patients with Celiac disease? Am J Gastroenterol (2007) 1.01
Use of HLA typing in diagnosing celiac disease in patients with type 1 diabetes. Diabetes Care (2005) 0.98
Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice. Eur J Immunol (2003) 0.97
Naturally-existing CD4(+)CD25(+)Foxp3(+) regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. J Autoimmun (2009) 0.94
Importance of gluten in the induction of endocrine autoantibodies and organ dysfunction in adolescent celiac patients. Am J Gastroenterol (2000) 0.93
Independent genetic regulation of T-cell and antigen-presenting cell participation in autoimmune islet inflammation. Diabetes (1998) 0.91
Animal models of type I (insulin-dependent) diabetes mellitus. J Pediatr Endocrinol Metab (1998) 0.91
The toll-like receptor signaling molecule Myd88 contributes to pancreatic beta-cell homeostasis in response to injury. PLoS One (2009) 0.90
Reg (regenerating) gene overexpression in islets from non-obese diabetic mice with accelerated diabetes: role of IFNbeta. Diabetologia (2006) 0.90
Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features. Mayo Clin Proc (2005) 0.88
Recirculation and homing of lymphocyte subsets: dual homing specificity of beta 7-integrin(high)-lymphocytes in nonobese diabetic mice. Blood (1996) 0.85
Shared genetic risk factors for type 1 diabetes and celiac disease. N Engl J Med (2008) 0.84
The prevalence of manifest and latent celiac disease in type 1 diabetes mellitus. Turk J Gastroenterol (2002) 0.84
Prevalence of coeliac disease in siblings of patients with Type I diabetes is related to the prevalence of DQB1*02 allele. Diabetologia (2001) 0.82
Spontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice. J Mol Cell Cardiol (2007) 0.82
Identification of immunodominant epitopes of alpha-gliadin in HLA-DQ8 transgenic mice following oral immunization. J Immunol (2005) 0.82
Changes in gastrointestinal permeability in celiac disease. Dig Dis (1999) 0.81
Modulation of insulitis and type 1 diabetes by transgenic HLA-DR3 and DQ8 in NOD mice lacking endogenous MHC class II. Hum Immunol (2002) 0.81
Elimination of dietary gluten and development of type 1 diabetes in high risk subjects. Rev Diabet Stud (2004) 0.80
Accelerated diabetes in rat insulin promoter-tumor necrosis factor-alpha transgenic nonobese diabetic mice lacking major histocompatibility class II molecules. Diabetes (2003) 0.78
Gluten-free diet in subjects at risk for type 1 diabetes: a tool for delaying progression to clinical disease? Adv Exp Med Biol (2005) 0.76
General screening for celiac disease is advisable in children with type 1 diabetes. Horm Metab Res (2002) 0.76
Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med (2003) 7.80
Multiple common variants for celiac disease influencing immune gene expression. Nat Genet (2010) 6.90
The Oslo definitions for coeliac disease and related terms. Gut (2012) 5.76
Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science (2013) 5.75
Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr (2005) 5.34
Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity (2011) 4.86
The prevalence of celiac disease in the United States. Am J Gastroenterol (2012) 4.77
Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science (2009) 4.45
American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology (2006) 4.41
ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol (2013) 4.36
Chikungunya: a re-emerging virus. Lancet (2011) 3.73
Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology (2009) 3.73
Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc (2012) 3.60
A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology (2013) 3.56
Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science (2010) 3.53
Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin Immunol (2006) 3.48
Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology (2011) 3.29
Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat Med (2011) 3.06
Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog (2010) 2.79
Patients with celiac disease are not followed up adequately. Clin Gastroenterol Hepatol (2012) 2.78
The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology (2011) 2.71
Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut (2012) 2.60
The incidence and risk of celiac disease in a healthy US adult population. Am J Gastroenterol (2012) 2.47
The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models. Inflamm Bowel Dis (2014) 2.46
Lymphocytic duodenosis and the spectrum of celiac disease. Am J Gastroenterol (2009) 2.26
Increased risk of systemic lupus erythematosus in 29,000 patients with biopsy-verified celiac disease. J Rheumatol (2012) 2.11
Is it necessary to assess for fat-soluble vitamin deficiencies in pediatric patients with newly diagnosed celiac disease? J Pediatr Gastroenterol Nutr (2014) 2.04
Acquisition of a multifunctional IgA+ plasma cell phenotype in the gut. Nature (2011) 2.04
Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity. Am J Gastroenterol (2009) 2.02
Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology (2010) 2.01
A report on the International Transglutaminase Autoantibody Workshop for Celiac Disease. Am J Gastroenterol (2009) 1.94
New humanized HLA-DR4-transgenic mice that mimic the sex bias of rheumatoid arthritis. Arthritis Rheum (2007) 1.92
Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria. Immunology (2005) 1.89
Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol (2010) 1.88
Hematologic manifestations of celiac disease. Blood (2006) 1.87
Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology (2010) 1.85
Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc (2004) 1.85
The liver in celiac disease. Hepatology (2007) 1.81
Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol (2002) 1.79
Routine duodenal biopsies to exclude celiac disease? Gastrointest Endosc (2003) 1.76
The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology (2006) 1.75
Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression. PLoS One (2011) 1.74
The insensitivity of endoscopic markers in celiac disease. Am J Gastroenterol (2002) 1.70
Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut (2007) 1.69
Increasing incidence of celiac disease in a North American population. Am J Gastroenterol (2013) 1.69
Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin Gastroenterol Hepatol (2003) 1.66
A prospective, randomized, double-blind, placebo-controlled trial of endoscopic steroid injection therapy for recalcitrant esophageal peptic strictures. Am J Gastroenterol (2005) 1.64
Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology (2008) 1.63
Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation. Liver Int (2008) 1.62
Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue. Clin Gastroenterol Hepatol (2010) 1.58
Adult intussusception in the last 25 years of modern imaging: is surgery still indicated? J Gastrointest Surg (2011) 1.54
Capsule endoscopy in nonresponsive celiac disease. Gastrointest Endosc (2011) 1.54
Chronic psychological stress in rats induces intestinal sensitization to luminal antigens. Am J Pathol (2006) 1.52
Anti-bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects. Arch Dermatol (2010) 1.52
Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol (2011) 1.52
Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol (2007) 1.51
Celiac disease. Curr Opin Gastroenterol (2010) 1.51
Intestinal microbial diversity during early-life colonization shapes long-term IgE levels. Cell Host Microbe (2013) 1.51
Training in small-bowel capsule endoscopy: assessing and defining competency. Gastrointest Endosc (2013) 1.50
Esophageal function testing with combined multichannel intraluminal impedance and manometry: multicenter study in healthy volunteers. Clin Gastroenterol Hepatol (2003) 1.48
Classification and management of refractory coeliac disease. Gut (2010) 1.48
Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis (2008) 1.48
Pathogen-specific risk of celiac disease following bacterial causes of foodborne illness: a retrospective cohort study. Dig Dis Sci (2013) 1.47
Significance of intraepithelial lymphocytosis in small bowel biopsy samples with normal mucosal architecture. Am J Gastroenterol (2003) 1.44
Pregnancy outcome and risk of celiac disease in offspring: a nationwide case-control study. Gastroenterology (2011) 1.44
Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. PLoS One (2012) 1.42
Neonatal maternal separation of rat pups results in abnormal cholinergic regulation of epithelial permeability. Am J Physiol Gastrointest Liver Physiol (2007) 1.38
Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol (2008) 1.38
Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am (2005) 1.35
Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients. Mayo Clin Proc (2007) 1.34
Loss of hepatocyte-nuclear-factor-4alpha affects colonic ion transport and causes chronic inflammation resembling inflammatory bowel disease in mice. PLoS One (2009) 1.32
The habitat, double life, citizenship, and forgetfulness of IgA. Immunol Rev (2012) 1.32
A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice. J Clin Invest (2003) 1.32
HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol (2002) 1.30
Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology (2010) 1.29
Collagenous gastritis: histopathologic features and association with other gastrointestinal diseases. Am J Surg Pathol (2009) 1.29
Neonatal maternal separation causes colonic dysfunction in rat pups including impaired host resistance. Pediatr Res (2005) 1.28
Reactivation of inflammatory bowel disease in a mouse model of depression. Gastroenterology (2009) 1.27
Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol (2009) 1.25
Correlation between cyclical epithelial barrier dysfunction and bacterial translocation in the relapses of intestinal inflammation. Inflamm Bowel Dis (2006) 1.24
Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease. Clin Gastroenterol Hepatol (2008) 1.23
A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J Clin Invest (2004) 1.23
Dermatitis herpetiformis. Int J Dermatol (2003) 1.23
Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy. J Clin Invest (2011) 1.22
Hepatitis B vaccine nonresponse and celiac disease. Am J Gastroenterol (2003) 1.20
Gluten-free diet: the medical and nutrition management of celiac disease. Nutr Clin Pract (2006) 1.19
An update in the diagnosis of coeliac disease. Histopathology (2010) 1.18
HLA class II transgenic mice mimic human inflammatory diseases. Adv Immunol (2008) 1.18
Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines. J Infect Dis (2002) 1.17
Transgenomic metabolic interactions in a mouse disease model: interactions of Trichinella spiralis infection with dietary Lactobacillus paracasei supplementation. J Proteome Res (2006) 1.16
Mechanism by which HLA-DR4 regulates sex-bias of arthritis in humanized mice. J Autoimmun (2010) 1.16
The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature (2008) 1.16
Variations in presentations of esophageal involvement in lichen planus. Clin Gastroenterol Hepatol (2010) 1.15
Homeland security: IgA immunity at the frontiers of the body. Trends Immunol (2012) 1.15
Long-term fracture risk in patients with celiac disease: a population-based study in Olmsted County, Minnesota. Dig Dis Sci (2007) 1.12